Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve
NCT05037552 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2023-03-13
Summary
Introduction : The most common technique used for ovarian cystectomy is the stripping technique. After stripping the cyst wall, the subsequent bleeding of the ovarian stromal wound is usually controlled by bipolar coagulation or/and by suturing. However, hemostasis achieved with bipolar coagulation could result in damage to the ovarian reserve. To avoid damage to healthy ovarian tissue, hemostasis using various topical hemostatic agents has been introduced to control post- cystectomy ovarian wound bleeding. Among these, FloSeal (Baxter Healthcare Corporation, Deer- field, IL, USA) is a hemostatic sealant composed of a gelatin-based matrix and thrombin solution.
Aim: The aim of the study is to evaluate the impact of topical hemostatic sealants and bipolar coagulation during laparoscopic ovarian benign cyst resection on ovarian reserve by comparing the rates of decrease in anti- Müllerian hormone (AMH).
Methods: A randomized prospective data collection was made on women aged 18-45 years who planned to have laparoscopic ovarian cystectomy at one of two institutions (n = 80), Montpellier University Hospital and Nimes University Hospital, France. Patients were randomly divided into two groups treated with either a topical hemostatic sealant (Floseal) or bipolar coagulation for hemostasis. Preoperative, 3-month and 6-month postoperative AMH levels were checked and the rates of decrease of AMH were compared.
Conditions
- Benign Ovarian Cyst
- Cystectomy
Interventions
- PROCEDURE
-
Bipolar coagulation
Cystectomy will be done via laparoendoscopic surgery After identifying the correct plane of cleavage, the stripping technique will be used. The cyst wall will be gently pulled down from the remaining ovary with two pairs of atraumatic forceps. Once the whole cyst wall will be separated from the ovary cortex, bleeding of the remaining ovarian stromal tissue will be controlled by bipolar coagulation. Then, the remnant tissue will be examined using irrigation and coagulated with minimal bipolar power (20-W current) on any sites that are bleeding.
- PROCEDURE
-
Coagulation by FLOSEAL haemostatic agent
Cystectomy will be done via laparoendoscopic surgery After identifying the correct plane of cleavage, the stripping technique will be used. The cyst wall will be gently pulled down from the remaining ovary with two pairs of atraumatic forceps. Once the whole cyst wall will be separated from the ovary cortex, bleeding of the remaining ovarian stromal tissue will be controlled by either hemostatic sealants (FloSeal). Using a laparoscopic applicator, FloSeal will be applied to the surface of bleeding sites under direct vision and the ovarian cortex was gently pressed for 2 min with small gauze.
Sponsors & Collaborators
-
Baxter Healthcare Corporation
collaborator INDUSTRY -
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Martha DURAES, MD · Montpellier University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-30
- Primary Completion
- 2025-01-30
- Completion
- 2025-09-30
Countries
- France
Study Locations
More Related Trials
-
Comparison Between Electrosurgical Energy and Hemostatic Sealants on Hemostasis in Laparoscopic Ovarian Cystectomy
NCT06913335 ·Status: RECRUITING ·Phase: NA
-
Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma
NCT06421857 ·Status: COMPLETED ·Phase: NA
-
Oocyte Freezing for Fertility Preservation in Benign Ovarian Tumors
NCT03823833 ·Status: COMPLETED
-
The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst
NCT00713778 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function
NCT04643106 ·Status: RECRUITING ·Phase: NA
-
Investigating Minimal Residual Disease in Autopreserved Ovarian Tissue in Cases of Neoplastic Pathology
NCT02888145 ·Status: COMPLETED
-
Lateral Occlusion of Uterine Artery in Total Laparoscopic Hysterectomy
NCT02709460 ·Status: UNKNOWN ·Phase: NA
-
Hysteroscopic Monopolar and Bipolar Resection
NCT00323999 ·Status: UNKNOWN ·Phase: NA
-
Intra-operative Ultrasound Guided Laparoscopic Ovarian Cystectomy as a Method of Fertility Preservation
NCT05032846 ·Status: UNKNOWN ·Phase: NA
-
Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues
NCT02900625 ·Status: COMPLETED
-
Effect of Laparoscopic Suturing Versus Bipolar Coagulation on Ovarian Reserve in Patients Undergoing Endometriotic Ovarian Cystectomy.
NCT03989856 ·Status: UNKNOWN ·Phase: NA
-
Impact of Salpingectomy on Ovarian Reserve
NCT02284711 ·Status: COMPLETED ·Phase: NA
-
Intrauterine Use of FloSeal: Is it Safe and Useful?
NCT01746628 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Occlusion Balloons of Both Internal Iliac Arteries in Caesarean Hysterectomy for PASD
NCT06356493 ·Status: COMPLETED
-
Ovarian Tissue Cryopreservation
NCT06710769 ·Status: RECRUITING ·Phase: NA
-
Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer
NCT01974193 ·Status: UNKNOWN ·Phase: PHASE3
-
Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping
NCT07200778 ·Status: RECRUITING ·Phase: NA
-
The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study
NCT05811286 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Versus Vaginal Hysterectomy in Women With Abnormal Uterine Bleeding Using Bipolar Vessel Sealer
NCT04237558 ·Status: COMPLETED ·Phase: NA
-
Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents
NCT06852313 ·Status: RECRUITING ·Phase: NA
-
Post-Market Evaluation of HEMOBLAST™ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery
NCT03873181 ·Status: COMPLETED
-
Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy
NCT04434066 ·Status: COMPLETED ·Phase: NA
-
Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions
NCT01344486 ·Status: TERMINATED ·Phase: PHASE4
-
Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy
NCT04423172 ·Status: UNKNOWN ·Phase: NA
-
Transumbilical Versus Lateral Transabdominal Removal of Benign Adnexal Masses Via Laparoscopy
NCT02704663 ·Status: UNKNOWN ·Phase: NA